Topiramate

NDC 50090-6828 · A-S Medication Solutions

Generic nameTopiramate

Dosage formTABLET

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength50 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

50090-6828-0 — 90 TABLET in 1 BOTTLE (50090-6828-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

47335-711 — Topiramate, 47335-712 — Topiramate, 50090-2102 — topiramate, 50090-2203 — topiramate, 50090-3389 — Topiramate, 50090-3461 — Topiramate, 50090-4614 — Topiramate, 50090-5309 — topiramate, 50090-5853 — topiramate, 50090-6827 — Topiramate, 50090-6895 — Topiramate, 50090-7067 — topiramate, 50090-7757 — topiramate, 50268-806 — topiramate, 50268-807 — topiramate, 50268-808 — topiramate, 50268-809 — topiramate, 50458-639 — topiramate, 50458-640 — topiramate, 50458-641 — topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels